LENZ
LENZ Therapeutics Inc
3.70$
-1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | 0.00 | 1.91 | 0.00 | 0.00 | 0.66 | |
| – | 0.01 | 0.09 | 1.06 | 0.30 | 0.00 | 0.02 | |
| – | -0.01 | -0.09 | 1.91 | -0.30 | 0.00 | 0.64 | |
| – | 1.10 | 4.58 | 2.69 | 7.31 | 1.40 | 0.65 | |
| – | – | 0.30 | 0.56 | 1.59 | 1.35 | 3.16 | |
| 0.00 | 1.61 | 7.20 | 3.25 | 8.89 | 2.75 | 3.80 | |
| 0.00 | -1.63 | -7.29 | -1.34 | -8.89 | -2.75 | -3.16 | |
| 0.01 | 0.00 | – | – | – | – | – | |
| -0.01 | -8.24 | -8.54 | -1.33 | -8.61 | -2.34 | -2.83 | |
| -0.02 | – | 0.06 | 0.04 | -0.02 | 0.00 | 0.02 | |
| -0.01 | -8.24 | -8.54 | -1.38 | -8.59 | -2.34 | -2.85 | |
| 0.02 | -8.22 | -8.45 | -1.33 | -8.61 | -2.34 | -2.82 |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.